Northeast Indiana research, LLC

Fort Wayne, Indiana 46825-1675

0 studies enrolling now · 17 studies all time

What they study most

Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy, Bladder Cancer, Bladder Neoplasm, Carcinoma in Situ, Erectile Dysfunction, Interstitial Cystitis, Mycobacterium, Neoplasm Recurrence, Local, Peyronie's Disease, Premature Ejaculation, Prostate Cancer

Studies at this site

• Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) — Stopped early
• A Study of AA4500 in Men With Peyronie's Disease — Completed
• Study of AA4500 in the Treatment of Peyronie's Disease — Completed
• The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease — Completed
• Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer — Stopped early
• Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer — Stopped early
• Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism — Completed
• Exploratory Study of Pagoclone in Men With Premature Ejaculation. — Completed
• R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence — Status unconfirmed
• A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer — Completed
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) — Completed
• Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism — Completed
• Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia — Stopped early
• A Study of DA-8159 in Subjects With Erectile Dysfunction — Completed
• Interstitial Cystitis — Completed